Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser H Hanna

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Clinical Lung Cancer|May 1, 2004
Second-line chemotherapy for non-small-cell lung cancer: recent data with pemetrexedNasser H Hanna
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Two drugs versus one drug in non-small-cell lung cancer: are we asking the right questions?Nasser H Hanna
Critical Reviews in Oncology/Hematology|October 27, 2004
Treatment of small cell lung cancerAnupama Kurup, Nasser H Hanna
Therapeutic Advances in Medical Oncology|July 27, 2011
Advanced non-small cell lung cancer: the role of maintenance therapyAnuj K Agarwala, Nasser H Hanna
Expert Review of Anticancer Therapy|May 27, 2004
Pemetrexed (Alimta): improving outcomes in malignant pleural mesotheliomaLeanne S Budde, Nasser H Hanna
Current Treatment Options in Oncology|December 22, 2004
Antimetabolites in the management of non-small cell lung cancerLeanne S Budde, Nasser H Hanna
Clinical Lung Cancer|December 5, 2003
Small-cell lung cancer: state of the artNasser H Hanna, Lawrance H Einhorn
Clinical Lung Cancer|June 10, 2005
Long-term survival in a patient with stage IV non-small-cell lung carcinoma after bone metastasectomyAnuj K Agarwala, Nasser H Hanna
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Postoperative chemotherapy for n2 non-small-cell lung cancer: conclusions are not black and white, but grayNasser H Hanna, Lawrence H Einhorn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Salvage therapy in patients with advanced non-small cell lung cancerPablo M Bedano, Nasser H Hanna
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Clinical Lung Cancer|May 1, 2004
Second-line chemotherapy for non-small-cell lung cancer: recent data with pemetrexedNasser H Hanna
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Two drugs versus one drug in non-small-cell lung cancer: are we asking the right questions?Nasser H Hanna
Critical Reviews in Oncology/Hematology|October 27, 2004
Treatment of small cell lung cancerAnupama Kurup, Nasser H Hanna
Therapeutic Advances in Medical Oncology|July 27, 2011
Advanced non-small cell lung cancer: the role of maintenance therapyAnuj K Agarwala, Nasser H Hanna
Expert Review of Anticancer Therapy|May 27, 2004
Pemetrexed (Alimta): improving outcomes in malignant pleural mesotheliomaLeanne S Budde, Nasser H Hanna
Current Treatment Options in Oncology|December 22, 2004
Antimetabolites in the management of non-small cell lung cancerLeanne S Budde, Nasser H Hanna
Clinical Lung Cancer|December 5, 2003
Small-cell lung cancer: state of the artNasser H Hanna, Lawrance H Einhorn
Clinical Lung Cancer|June 10, 2005
Long-term survival in a patient with stage IV non-small-cell lung carcinoma after bone metastasectomyAnuj K Agarwala, Nasser H Hanna
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Postoperative chemotherapy for n2 non-small-cell lung cancer: conclusions are not black and white, but grayNasser H Hanna, Lawrence H Einhorn
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Salvage therapy in patients with advanced non-small cell lung cancerPablo M Bedano, Nasser H Hanna
Pageof 9